ORIGIN

It didn't begin in a cosmetics lab. It began in anatomy.

Lycopus lucidus has been used for centuries to cool and calm the skin. What it had never been given was a structural explanation โ€” until an anatomist asked the question differently.

01

A plant with a long history

In traditional use, Lycopus was applied to draw heat out of the skin and settle irritation. Effective, but never explained โ€” the reason it worked stayed unexamined.

02

An anatomist's question

The research behind this patent was led by a professor of anatomy โ€” a field concerned with the structure of tissue, not with cosmetic formulation. The question was structural: why does thin, immature or compromised skin react so strongly to what touches it?

03

A composition built on the answer

The extraction method and the composition were then designed around that answer, rather than around the plant's reputation โ€” and registered as a patent held by Custics.

LYCOPUS LUCIDUS LEAF EXTRACT โ€” Korean Patent No. 10-2144566, registered August 7, 2020. Patentee: Custics Co., Ltd.
View deep-layer recovery data & original image

Scientifically Proven to Restore Deep Skin Layers. Lycopus Lucidus Leaf Extract penetrates beyond the skin surface and delivers restorative effects deep within the dermal layers. Application visibly repaired damaged tissue and reduced inflammation, confirming its efficacy in soothing sensitive skin.

Animals in an atopic dermatitis model treated with Lycopus Lucidus Leaf Extract showed remarkable recovery of skin tissue.
MECHANISM

Where sensitivity begins โ€” and where Lycopus acts.

Skin sensitivity is a chain reaction. Before redness ever appears, two intracellular signalling pathways decide how loudly the skin will respond.

โ˜€

External trigger

Friction, dryness, heat, environmental irritants

โ†’
LYCOPUS ACTS HERE
โšก

NF-ฮบB & MAPK

The alarm switch โ€” activation of the response

โ†’
๐Ÿ’ง

Inflammatory response

Cytokine release, redness and heat

โ†’
ใ€œ

Reactive skin

Visible sensitivity, discomfort, itch

LYCOPUS LUCIDUS LEAF EXTRACT โ€” Pathway model based on Min GY et al., Mol Med Rep 2021;24(6):827 ยท Shin TY et al., Toxicol Appl Pharmacol 2005;209(3):255โ€“262. Original illustration for explanatory purposes.
MEASURED EFFECT

Turning the alarm switch down.

In cellular studies, Lycopus lucidus leaf extract reduced the activation of both signalling pathways that govern the skin's sensitivity response.

100
Untreated
50
Lycopus
NF-ฮบB
Key regulator of the inflammatory response
Activation โ†“ 50%
100
Untreated
60
Lycopus
MAPK
Stress-response signalling pathway
Activation โ†“ 40%
RELATIVE ACTIVATION MARKER, UNTREATED = 100 โ€” Min GY, Kim EY, Hong S, et al. Mol Med Rep 2021;24(6):827. doi:10.3892/mmr.2021.12467. Original chart; values indexed to untreated = 100 for comparison.
View original citation figure

Phenolic & Flavonoid Complex for Skin Soothing and Recovery. Extensive research has demonstrated that Lycopus Lucidus Leaf Extract directly interacts with cellular signaling pathways involved in skin sensitivity and inflammation โ€” providing strong evidence that it acts at the very first stage of the skin's sensitivity response, the "alarm switch," effectively calming excessive reactivity and restoring balance.

Kim et al. (2021), Journal of Inflammation Research
CROSS-VERIFICATION

Three independent studies. One consistent finding.

The soothing mechanism of Lycopus lucidus leaf extract has been examined across separate research groups and separate models โ€” and the results point the same way.

2021

Molecular Medicine Reports

Min GY, Kim EY, Hong S, et al. ยท 24(6):827
In a model simulating highly sensitive skin, activation of NF-ฮบB and MAPK signalling within skin tissue was significantly reduced.
TISSUE-LEVEL SIGNALLING
2009

Food Chemistry

Sล‚usarczyk S, Hajnos M, Skalicka-Woลบniak K, Matkowski A ยท 113(1):134โ€“138
The polyphenol fraction of the plant was characterised and its antioxidant activity measured, identifying the compounds behind the effect.
POLYPHENOL PROFILE
2005

Toxicology and Applied Pharmacology

Shin TY, Kim SH, Suk K, et al. ยท 209(3):255โ€“262
Secretion of inflammatory substances from the cells that trigger immediate sensitivity reactions was reduced โ€” acting before irritation begins.
PRE-EMPTIVE CALMING
REFERENCES Min GY, Kim EY, Hong S, et al. Mol Med Rep. 2021;24(6):827. doi:10.3892/mmr.2021.12467 ยท Sล‚usarczyk S, Hajnos M, Skalicka-Woลบniak K, Matkowski A. Food Chem. 2009;113(1):134โ€“138. doi:10.1016/j.foodchem.2008.07.037 ยท Shin TY, Kim SH, Suk K, et al. Toxicol Appl Pharmacol. 2005;209(3):255โ€“262. doi:10.1016/j.taap.2005.04.011. Figures are original visualizations by Lesstopy. Cited studies examined the botanical extract in laboratory models and do not constitute claims for this cosmetic product.
View original study figures

Study 1: Min et al. (2021), Molecular Medicine Reports. This study used an animal model designed to simulate highly sensitive skin conditions. It was confirmed that the activation of NF-ฮบB and MAPK signaling within the skin tissue was significantly reduced.

Min et al. (2021), Molecular Medicine Reports

Study 2: Shin et al. (2005), Archives of Pharmacal Research. This study revealed that Lycopus Lucidus Leaf Extract reduces the secretion of inflammatory substances from cells responsible for triggering immediate skin sensitivity reactions โ€” soothing already activated responses while also helping prevent the initial cascade of sensitivity.

Shin et al. (2005), Archives of Pharmacal Research
PROPRIETARY PATENT

The extract behind Lesstopy is patented.

Lesstopy does not license this botanical from a supplier. The composition using Lycopi Herba extract as an active ingredient is registered as a patent held by Custics, the brand's own company.

โœ“
10-2144566
KOREAN INTELLECTUAL PROPERTY OFFICE
Patent number
10-2144566
Subject
A composition comprising Lycopi Herba extract as an active ingredient
Patentee
Custics Co., Ltd. โ€” the company behind Lesstopy
Filed
October 10, 2018 ยท Application No. 10-2018-0120220
Registered
August 7, 2020
Granted by
Korean Intellectual Property Office (KIPO)
NOTE A patent is a grant of intellectual property rights over an invention and relates to the botanical extract as a raw material. It is not a determination of efficacy for any finished cosmetic product, and Lesstopy ATO Cream is a cosmetic โ€” not a treatment for any medical condition.
View certificate scan

Lesstopy's Proprietary Patent โ€” Unveiling the Mechanism of Skin Recovery. The soothing and moisturizing mechanism of Lycopus Lucidus Leaf Extract goes beyond simple efficacy โ€” it has been scientifically proven to enhance the skin's natural ability to recover. Based on these research findings, Lesstopy has obtained a proprietary patent for the composition of Lycopus Lucidus Leaf Extract.

Patent Certificate No. 10-2144566, Korean Intellectual Property Office